Cystic Fibrosis
Showing NaN - NaN of 112
Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis
Active, not recruiting
- Cystic Fibrosis
- Pancreatic Insufficiency
- Abdominal Ultrasound
- Sample collection procedures
-
Aurora, Colorado
- +10 more
Mar 23, 2022
Biological & Clinical Effects of Significantly Corrected CFTR
Active, not recruiting
- Cystic Fibrosis
- Ivacaftor or elexacaftor/tezacaftor/ivacaftor
-
Birmingham, Alabama
- +33 more
Feb 2, 2022
Cystic Fibrosis Trial in Worldwide (VX-371 + HS, Hypertonic saline, Placebo)
Completed
- Cystic Fibrosis
- VX-371 + HS
- +4 more
-
Little Rock, Arkansas
- +39 more
Jul 8, 2021
Cystic Fibrosis and Cognitive Function
Completed
- Cystic Fibrosis
-
Minneapolis, MinnesotaClinical and Translational Science Institute and Center for Magn
Jun 30, 2021
Expanded to Additional Genotypes and Extended for Long Therm
Completed
- Cystic Fibrosis
-
Birmingham, Alabama
- +35 more
Jun 28, 2021
Cystic Fibrosis Trial in United States (azithromycin, (for azithromycin), inhaled tobramycin)
Cystic Fibrosis Trial in Worldwide (Inhaled mannitol, Placebo Comparator: Arm B - Control)
Completed
- Cystic Fibrosis
- Inhaled mannitol
- Placebo Comparator: Arm B - Control
-
Mobile, Alabama
- +99 more
Oct 6, 2020
Cystic Fibrosis Trial in Worldwide (VX-659/TEZ/IVA, IVA, Placebo)
Cystic Fibrosis Trial in Canada, United States (7% Hypertonic Saline (HS), 0.9% Isotonic Saline (IS))
Completed
- Cystic Fibrosis
- 7% Hypertonic Saline (HS)
- 0.9% Isotonic Saline (IS)
-
Birmingham, Alabama
- +24 more
Jan 10, 2020